UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Tet3 regulates cellular identity and DNA methylation in neural progenitor cells

Cellular and molecular life sciences : CMLS, 2020-07, Vol.77 (14), p.2871-2883

2020

Link zum Volltext

Verfügbarkeit prüfen

A scoping review on early inflammatory bowel disease: definitions, pathogenesis, and impact on clinical outcomes

Therapeutic Advances in Gastroenterology, 2022-01, Vol.15, p.17562848221142673-17562848221142673

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Tet3 regulates cellular identity and DNA methylation in neural progenitor cells

Cellular and molecular life sciences : CMLS, 2020-07, Vol.77 (14), p.2885-2885

2020

Link zum Volltext

Verfügbarkeit prüfen

What forecasting the prevalence of inflammatory bowel disease may tell us about its evolution on a national scale

Therapeutic advances in gastroenterology, 2019-06, Vol.12, p.1756284819860044

2019

Link zum Volltext

Verfügbarkeit prüfen

Composite outcomes in observational studies of Crohn’s disease: a systematic review and meta-analysis

Therapeutic advances in gastroenterology, 2022, Vol.15, p.17562848221092754-17562848221092754

2022

Link zum Volltext

Verfügbarkeit prüfen

Incidence Trends of Inflammatory Bowel Disease in a Southern European Country: A Mirror of the Western World?

Clinical and translational gastroenterology, 2022-05, Vol.13 (5), p.e00481-e00481

2022

Link zum Volltext

Verfügbarkeit prüfen

Rehospitalization rates, costs, and risk factors for inflammatory bowel disease: a 16-year nationwide study

Therapeutic advances in gastroenterology, 2020, Vol.13, p.1756284820923836-1756284820923836

2020

Link zum Volltext

Verfügbarkeit prüfen

Viable Mycobacterium avium subsp. paratuberculosis Colonizes Peripheral Blood of Inflammatory Bowel Disease Patients

Microorganisms (Basel), 2023-06, Vol.11 (6), p.1520

2023

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory Bowel Disease Reoperation Rate Has Decreased Over Time If Corrected by Prevalence

Clinical and translational gastroenterology, 2020-09, Vol.11 (9), p.e00227-e00227

2020

Link zum Volltext

Verfügbarkeit prüfen

How can internal marketing practices help achieve organizational success?

Revista de administração pública (Rio de Janeiro), 2023-07, Vol.57 (4), p.1-22

2023

Link zum Volltext

Verfügbarkeit prüfen

TET enzymes and DNA hydroxymethylation in neural development and function — How critical are they?

Genomics (San Diego, Calif.), 2014-11, Vol.104 (5), p.334-340

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of Crohn’s Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis

Inflammatory bowel diseases, 2023-08, Vol.29 (8), p.1231-1243

2023

Link zum Volltext

Verfügbarkeit prüfen

The Magnitude of Crohn’s Disease Direct Costs in Health Care Systems (from Different Perspectives): A Systematic Review

Inflammatory bowel diseases, 2022-10, Vol.28 (10), p.1527-1536

2022

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl peptidase 4 (DPP4) in fecal samples: validation of the extraction methodology and stability in short-term storage conditions

Clinical chemistry and laboratory medicine, 2023-08, Vol.61 (9), p.1636

2023

Link zum Volltext

Verfügbarkeit prüfen

Mo1847 THE INFLUENCE OF PERSISTENT ACTIVE INFLAMMATION ON IFX PHARMACOKINETIC MODELING AND DISEASE PROGRESSION ASSESSMENT: FINDINGS FROM A PROSPECTIVE REAL-WORLD STUDY IN INFLAMMATORY BOWEL DISEASE PATIENTS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1141-S-1141

2024

Link zum Volltext

Verfügbarkeit prüfen

A IMPORTÂNCIA DAS PRÁTICAS DE MARKETING INTERNO PARA O SUCESSO ORGANIZACIONAL

Revista Gestão em Análise, 2019-12, Vol.8 (3), p.66

Santiago, Mafalda Maria Pinto Farrim Fernandes

2019

Link zum Volltext

Verfügbarkeit prüfen

Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 Years

Clinical gastroenterology and hepatology, 2022-09, Vol.20 (9), p.2059-2073.e7

2022

Link zum Volltext

Verfügbarkeit prüfen

Hospitalization trends of the Inflammatory Bowel Disease landscape: A nationwide overview of 16 years

Digestive and liver disease, 2019-07, Vol.51 (7), p.952-960

2019

Link zum Volltext

Verfügbarkeit prüfen

Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study

Inflammatory bowel diseases, 2020-04, Vol.26 (5), p.746-755

2020

Link zum Volltext

Verfügbarkeit prüfen

Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab

Digestive and liver disease, 2024-05, Vol.56 (5), p.737-743

2024

Link zum Volltext

Verfügbarkeit prüfen

Su1531: SUBCLINICAL PERSISTENT INFLAMMATION AS RISK FACTOR FOR CROHN'S DISEASE PROGRESSION: FINDINGS FROM A PROSPECTIVE REAL-WORLD STUDY OF 2 YEARS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-616-S-616

2022

Link zum Volltext

Verfügbarkeit prüfen

Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy

Clinical gastroenterology and hepatology, 2021-12, Vol.19 (12), p.2567-2576.e9

2021

Link zum Volltext

Verfügbarkeit prüfen

Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis

United European gastroenterology journal, 2023-03, Vol.11 (2), p.202-217

2023

Link zum Volltext

Verfügbarkeit prüfen

Viable IMycobacterium avium/I subsp. Iparatuberculosis/I Colonizes Peripheral Blood of Inflammatory Bowel Disease Patients

Microorganisms (Basel), 2023-06, Vol.11 (6)

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(61)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Tet3 regulates cellular identity and DNA methylation in neural progenitor cells

A scoping review on early inflammatory bowel disease: definitions, pathogenesis, and impact on clinical outcomes

Correction to: Tet3 regulates cellular identity and DNA methylation in neural progenitor cells

What forecasting the prevalence of inflammatory bowel disease may tell us about its evolution on a national scale

Composite outcomes in observational studies of Crohn’s disease: a systematic review and meta-analysis

Incidence Trends of Inflammatory Bowel Disease in a Southern European Country: A Mirror of the Western World?

Rehospitalization rates, costs, and risk factors for inflammatory bowel disease: a 16-year nationwide study

Viable Mycobacterium avium subsp. paratuberculosis Colonizes Peripheral Blood of Inflammatory Bowel Disease Patients

Inflammatory Bowel Disease Reoperation Rate Has Decreased Over Time If Corrected by Prevalence

How can internal marketing practices help achieve organizational success?

TET enzymes and DNA hydroxymethylation in neural development and function — How critical are they?

Impact of Crohn’s Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis

The Magnitude of Crohn’s Disease Direct Costs in Health Care Systems (from Different Perspectives): A Systematic Review

Dipeptidyl peptidase 4 (DPP4) in fecal samples: validation of the extraction methodology and stability in short-term storage conditions

Mo1847 THE INFLUENCE OF PERSISTENT ACTIVE INFLAMMATION ON IFX PHARMACOKINETIC MODELING AND DISEASE PROGRESSION ASSESSMENT: FINDINGS FROM A PROSPECTIVE REAL-WORLD STUDY IN INFLAMMATORY BOWEL DISEASE PATIENTS

A IMPORTÂNCIA DAS PRÁTICAS DE MARKETING INTERNO PARA O SUCESSO ORGANIZACIONAL

Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 Years

Hospitalization trends of the Inflammatory Bowel Disease landscape: A nationwide overview of 16 years

Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study

Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab

Su1531: SUBCLINICAL PERSISTENT INFLAMMATION AS RISK FACTOR FOR CROHN'S DISEASE PROGRESSION: FINDINGS FROM A PROSPECTIVE REAL-WORLD STUDY OF 2 YEARS

Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy

The influence of subclinical active inflammation on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patients

Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis

Viable IMycobacterium avium/I subsp. Iparatuberculosis/I Colonizes Peripheral Blood of Inflammatory Bowel Disease Patients

Suchergebnisse filtern